Butyrate supplementation for an extended period in mice prevents diet-induced obesity and improves markers like insulin sensitivity and lipid profiles by enhancing fatty acid oxidation and increasing sympathetic outflow to BAT (75). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.